Liquid biopsy based HER2 amplification status in gastric cancer patients indicates clinical response

Gastric carcinomas are among the most common cancers in Germany, with approximately 18,000 new cases per year. About 10 years ago, based on results of the Trastuzumab for gastric cancer (ToGA) trial, the addition of the monoclonal antibody trastuzumab to a platinum-fluoropyrimidine chemotherapy back...

Descripción completa

Detalles Bibliográficos
Autores principales: Klein-Scory, Susanne, Ladigan-Badura, Swetlana, Mika, Thomas, Verdoodt, Berlinda, Tannapfel, Andrea, Pohl, Michael, Schroers, Roland, Baraniskin, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665680/
https://www.ncbi.nlm.nih.gov/pubmed/38027576
http://dx.doi.org/10.1016/j.heliyon.2023.e21339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665680/
https://www.ncbi.nlm.nih.gov/pubmed/38027576
http://dx.doi.org/10.1016/j.heliyon.2023.e21339

Ejemplares similares